Yusuf KARAKAŞ

Hakkari İlinde Görülen Kanser Türlerinin ve Prevalanslarının Değerlendirilmesi

Amaç: Hakkari ilinde kanser prevalansını belirlemekGereç ve Yöntem: Mayıs 2017 – Aralık 2018 arasında Hakkari’de kanser tanısıyla sağlık kuruluşlarına başvuran erişkin hastalar değerlendirildi. Demografik özellikleri ve tanıları belirlendi.Bulgular: Kanser tanısıyla başvuran 631 hastanın 344 %54.5 ’i kadın, 287 %45.5 ’i erkekti. Kadınlarda ilk beş kanser türü sırasıyla; meme, diferansiye tiroid, kolorektal, özofagus ve mide kanseri, erkeklerde ise; mide, akciğer, prostat, kolorektal, ve özofagus kanseri olarak belirlendi.Sonuçlar: Hakkari ilinde mide ve özofagus kanserleri her iki cins içinde, sık görülen kanser türleri arasında yer almaktadır

Tievaluation of Cancer Types and Prevalence In The Province of Hakkari, Turkey

Aim: To determine the prevalence of cancer in the province of Hakkari, Turkey.Methods: All adult patients diagnosed with cancer who applied to a health care provider in Hakkari between May 2017 and December 2018 were evaluated. Demographic features and types of cancer were determined.Results: Of the 621 patients diagnosed with cancer, 344 54.5% were female, and 287 45.5% were male. The five most common types of cancer in female patients were; breast cancer, differentiated thyroid cancer, colorectal cancer, esophagus cancer, gastric cancer. In male patients; gastric cancer, lung cancer, prostate cancer, colorectal cancer, esophagus cancer, respectively.Conclusion: Gastric and esophagus cancer are among the types of cancer with the highest prevalence in the province of Hakkari

Keywords:

Hakkari, Gastric cancer Esophagus cancer,

PDF

___

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 2018; 68: 394-424. [CrossRef]

Nazlıgül Y, Sabuncu T, Dalmaz M, Cebeci B, Bitiren M, Kösecik M. Şanlıurfa’da 1990-1994 Yılları Arasında Kanser Vakaları. Van Tıp Dergisi 1997; 4: 198-200.

Youn Nam S, Park BJ, Nam JH, Ryu KH, Kook M-C, Kim J, et al. Association of current Helicobacter pylori infection and metabolic factors with gastric cancer in 35,519 subjects: A cross-sectional study. United European gastroenterology journal 2019; 7: 287-96. [CrossRef]

Yalcin S. Gastric cancer in Turkey—a bridge between West and East. Gastrointestinal cancer research: GCR 2009; 3: 29.

Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Gastric cancer as preventable disease. Clinical Gastroenterology and Hepatology 2017; 15: 1833-43. [CrossRef]

Turk J Gastroenterol 2003; 14: 50-3.

Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. World Health Organization; 2010.

Kolonel LN, Hankin JH, Nomura AM. Multiethnic studies of diet, nutrition and cancer in Hawaii. Diet, nutrition, and cancer 1986:29-40.

Lunet N, Valbuena C, Vieira AL, Lopes C, Lopes C, David L, et al. Fruit and vegetable consumption and gastric cancer by location and histological type: case–control and meta-analysis. European Journal of Cancer Prevention 2007; 16: 312-27. [CrossRef]

Gomez SL, Shariff‐Marco S, DeRouen M, Keegan TH, Yen IH, Mujahid M, et al. The impact of neighborhood social and built environment factors across the cancer continuum: current research, methodological considerations, and future directions. Cancer 2015;121: 2314-30. [CrossRef]

Kim Y, Park J, Nam B-H, Ki M. Stomach cancer incidence rates among Americans, Asian Americans and Native Asians from 1988 to 2011. Epidemiol health 2015; 37:e2015006. [CrossRef]

Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment pharmacol ther. 2014; 40: 250-60. [CrossRef]

Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 2014;23: 700-13. [CrossRef]

Lui FH, Tuan B, Swenson SL, Wong RJ. Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992–2009 SEER data. Digestive diseases and sciences 2014;59:3027- 34. [CrossRef]

Wu X, Chen VW, Andrews PA, Ruiz B, Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer causes & control 2007;18: 585-93. [CrossRef]

González CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. International journal of cancer 2012; 130: 745-53. [CrossRef]

Cancer IAfRo. Personal habits and indoor combustions. IARC monographs on the evaluation of carcinogenic risks to humans 2012; 100: 319-31.

Parkin DM. The global health burden of infection‐associated cancers in the year 2002. Int j cancer 2006; 118: 3030-44. [CrossRef]

Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, et al. Recent patterns in gastric cancer: a global overview. Int j cancer 2009; 125: 666-73. [CrossRef]

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer manag res. 2018; 10: 239-48. [CrossRef]

Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Rev Gastroenterol hepatol. 2014; 11: 28-35. [CrossRef]

Huang X, Hong C, Peng Y, Yang S, Huang L, Liu C, et al. The Diagnostic Value Of Serum IGFBP7 In Patients With Esophageal Squamous Cell Carcinoma. J Cancer 2019;10:2687-93. [CrossRef]

Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. High‐ temperature beverages and foods and esophageal cancer risk—A systematic review. Int J Cancer 2009;125:491-524. [CrossRef]

Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shakeri R, et al. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009; 338: b929. [CrossRef]

Rasool S, Ganai B, Syed Sameer S, Masood A. Esophageal cancer: associated factors with special reference to the Kashmir Valley. Tumori Journal 2012; 98: 191-203. [CrossRef]

Wu M, Liu AM, Kampman E, Zhang ZF, van’t Veer P, Wu DL, et al. Green tea drinking, high tea temperature and esophageal cancer in high‐and low‐risk areas of Jiangsu Province, China: A population‐ based case–control study. Int J Cancer 2009;124:1907-13. [CrossRef]

Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev 2016; 25: 16-27. [CrossRef]

Hayden JD, Cawkwell L, Sue‐Ling H, Johnston D, Dixon MF, Quirke P, et al. Assessment of microsatellite alterations in young patients with gastric adenocarcinoma. Cancer 1997; 79: 684-7. [CrossRef]

De Vries AC, Van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-52. [CrossRef]

Leung WK, Wu M-s, Kakugawa Y, Kim JJ, Yeoh K-g, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9: 279-87. [CrossRef]

Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann surg 2005; 241: 27-39. [CrossRef]

Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto I. Evaluation of a mass screening program for stomach cancer with a case‐control study design. Int J Cancer 1986; 38: 829-33. [CrossRef]

Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fukao A. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One 2013; 8: e79088. [CrossRef]

Lin S, Qi W, Han K, Gan Z, Yao Y, Miu D. Prognostic value of SOX2 in digestive tumors: a meta-analysis. Hepatogastroenterology. 2014;61:1274-8.

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: Cancer J Clin 2005; 55: 74-108. [CrossRef]

Hamashima C, Group SR, Guidelines GDGfGCS. Update version of the Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2018; 48: 673-83. [CrossRef]

Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015;64:381-7. [CrossRef]